Searched for
BIONTECH VACCINE CANDIDATE
Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccineModerna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...- BioNTech expects Omicron-adapted vaccine deliveries as soon as OctoberPending regulatory approval, both vaccines would be supplied in time for booster campaigns come autumn, said the company. Second-quarter re...
- Pfizer, BioNTech begin vaccine trial to target new strainThe study will have 1,420 subjects, with three cohorts examining different regimens of the current Pfizer-BioNTech Covid vaccine or an Omic...
- Pfizer-BioNTech begin trials of new vaccine against Omicron variantThe study will have 1420 subjects, with three cohorts examining different regimens of the current Pfizer-BioNTech COVID vaccine or an Omicr...
- Pfizer begins testing use of pnuemococcal vaccine along with COVID-19 booster shotThe study will include 600 adults over 65 years who will be recruited from the late-stage study of the Pfizer-BioNTech COVID-19 vaccine, an...
- France's Sanofi to manufacture vaccines developed by rival Pfizer-BioNTechThe Germany-based BioNTech will initially produce the vaccines at Sanofi facilities in Frankfurt, starting in the summer, according to a Sa...
- US FDA probing 'about five' allergic reactions to Pfizer COVID-19 vaccineThe FDA official said that one component of the vaccine, polyethylene glycol, may be the cause of the allergic reactions seen in both the U...
- Fosun Pharma to buy 100 million doses of BioNTech's COVID-19 vaccine for mainland ChinaFosun said it will be entitled to 60% of annual gross profit from sales of doses that it will make from imported bulk ingredients, and 65% ...
- Data from by Pfizer/BioNTech, Moderna for COVID-19 vaccines 'very robust': EMA"We have a data set of over 30,000 subjects who have been followed through the clinical trials. This gives us a very robust data set on whi...
- Pfizer-BioNTech vaccine documents hacked in EU cyberattackThe Dutch national police high-tech crime team was involved in the probe into the cyberattack, but police gave no more information, the Dut...
- How the world has sped up vaccine approvalsAs authorities in the US and Europe probe other candidates, here is how countries have sped up their approval procedures to face up to the ...
- UK secures 2 million more doses of Moderna's COVID-19 vaccineModerna's experimental vaccine is 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial. Deliveries to Brita...
- EU regulator could approve Covid vaccines 'late 2020, early 2021'The Amsterdam-based EMA is carrying out "rolling reviews" designed to speed up vaccine approval times on three candidates: Pfizer-BioNTech,...
- Pfizer shares surge nearly 4% on vaccine reportGlobal drugmakers Pfizer and BioNTech said on Wednesday that their COVID-19 vaccine was found 95 per cent effective in the final analysis o...
- EU says more vaccine deals to come soon as Moderna unveils positive resultsOn Aug. 24 the EU Commission, which conducts talks with vaccine makers on behalf of EU states, said exploratory talks with Moderna had been...
- UK says expects to receive 10 million doses of Pfizer/BioNTech vaccine this yearThe spokesman said that Britain had now ordered 40 million doses of the candidate vaccine developed by Pfizer and BioNTech, one of six that...
- Pfizer not yet ready to release COVID-19 vaccine data from late-stage trialPharma major Pfizer Inc said the company could release data on whether or not the vaccine works as early as this month.
- U.S. to pay Pfizer and BioNTech $1.95 billion to produce millions of doses of COVID-19 vaccinePfizer will deliver the doses if the product receives Emergency Use Authorization or licensure from the U.S. Food and Drug Administration, ...
- Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' statusTwo experimental coronavirus vaccines jointly developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer have received ...
- German company begins testing possible vaccineBioNTech said in a statement that in a next step, it will begin increasing the dose of BNT162 in a trial involving about 200 participants a...
Load More
